NCT00265408

Brief Summary

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2005

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

December 12, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 14, 2005

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2007

Completed
Last Updated

December 8, 2014

Status Verified

March 1, 2007

First QC Date

December 12, 2005

Last Update Submit

December 5, 2014

Conditions

Ischemic Stroke

Keywords

Cervicocephalic Arterial Dissection

Outcome Measures

Primary Outcomes (1)

  • Incidence of stroke by one year.

    1 year

Secondary Outcomes (3)

  • Recurrent dissection by one year.

    1 year

  • Incidence of TIA by one year.

    1 year

  • Incidence of major and minor bleeding episodes by one year.

    1 year

Study Arms (2)

aspirin

EXPERIMENTAL
Drug: aspirin

warfarin

EXPERIMENTAL
Drug: warfarin

Interventions

aspirinDRUG
aspirin
warfarinDRUG
warfarin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical and imaging diagnosis of cervicocephalic arterial dissection within 3 months.

You may not qualify if:

  • Any contraindication to aspirin or warfarin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSD Medical Center

San Diego, California, 92103, United States

Location

MeSH Terms

Conditions

Ischemic Stroke

Interventions

AspirinWarfarin

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

SalicylatesHydroxybenzoatesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals4-HydroxycoumarinsCoumarinsBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Matt B Jensen, MD

    UCSD Stroke Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 12, 2005

First Posted

December 14, 2005

Study Start

December 1, 2005

Study Completion

March 1, 2007

Last Updated

December 8, 2014

Record last verified: 2007-03

Locations

US(1)